This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Wolfram Haensel: Innovator in Potassium Channel Inhibition
Introduction
Wolfram Haensel is a notable inventor based in Kronshagen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target potassium channels. With a total of 2 patents, his work focuses on innovative solutions for treating autoimmune diseases.
Latest Patents
Haensel's latest patents include groundbreaking work on 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage-gated Kv1.3 potassium channel. These compositions of matter comprise 5-phenoxyalkoxypsoralen compounds, which are useful in treating various diseases or disorders in both human and animal subjects. The compounds specifically inhibit potassium channels, including the Kv1.3 channel, and some therapeutic effects may be attributed to this inhibition. Notably, these compounds demonstrate selectivity for certain potassium channels, such as Kv1.3, over others like Kv1.5.
Career Highlights
Wolfram Haensel is affiliated with the University of California, where he continues to advance his research in the field. His innovative approach to potassium channel inhibition has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Haensel has collaborated with esteemed colleagues, including Heike Wulff and Ananthakrishnan Sankaranarayanan. These partnerships have further enriched his research and contributed to the advancement of his patented technologies.
Conclusion
Wolfram Haensel's contributions to the field of medicinal chemistry, particularly in potassium channel inhibition, highlight his role as an influential inventor. His work promises to pave the way for new treatments for autoimmune diseases and other disorders.